Table 2. Results of screening for of clinical samples from 23 US states for pandemic (H1N1) 2009 virus and respiratory pathogen gene targets, May–October 2009*.
| No. (%) samples | Viruses detected, no. (%) samples |
|||||||
|---|---|---|---|---|---|---|---|---|
| Adeno | Coxackie/echo | Metapneumo | Influenza A | Influenza B | Parainfluenza | RS | Rhino | |
| Pandemic (H1N1) 2009 positive, 3,110 (29.270) |
1 (0.032) |
13 (0.418) |
0 |
0 |
0 |
3 (0.096) |
0 |
7 (0.225) |
| Pandemic (H1N1) 2009 negative, 7,514 (70.730) |
17 (0.226) |
650 (8.651)
|
14 (0.186) |
3 (0.040) |
2 (0.027) |
173 (2.302) |
3 (0.040) |
449 (5.976)
|
| Total, 10,624 (100.000) | 18 (0.169) | 663 (6.240) | 14 (0.132) | 3 (0.028) | 2 (0.019) | 176 (1.656) | 3 0.(028) | 456 (4.292) |
*RS, respiratory syncytial. Boldface indicates predominant pathogens.